Publication Name	World Journal of Gastroenterology
Manuscript ID	79880
Country	Italy

Received	2022-09-10 11:14
Peer-Review Started	2022-09-10 11:16
To Make the First Decision
Return for Revision	2022-10-19 21:27
Revised	2022-11-01 17:53
Second Decision	2022-11-11 03:14
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-11-17 18:27
Articles in Press	2022-11-17 18:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-11-18 09:28
Publish the Manuscript Online	2022-11-25 02:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure
Manuscript Source	Invited Manuscript
All Author List	Marco Pizzoferrato, Pierluigi Puca, Sara Ennas, Giovanni Cammarota and Luisa Guidi
ORCID	Author(s) ORCID Number Marco Pizzoferrato http://orcid.org/0000-0003-2017-7412 Pierluigi Puca http://orcid.org/0000-0003-0935-8853 Giovanni Cammarota http://orcid.org/0000-0002-3626-6148 Luisa Guidi http://orcid.org/0000-0003-3320-7094
Funding Agency and Grant Number
Corresponding Author	Luisa Guidi, MD, PhD, Professor, UOC Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli, 8, Rome 00168, Italy. luisa.guidi@policlinicogemelli.it
Key Words	Short bowel syndrome; Intestinal failure; Crohn’s disease; Glucagon-like peptide-2 analogues; Teduglutide; Apraglutide; Glepaglutide
Core Tip	Short bowel syndrome with intestinal failure and chronic dependency on parenteral support are rare but severe complications of Crohn’s disease (CD) after repeated intestinal resections. New therapeutic options are available, including glucagon-like peptide-2 analogues. Their use in CD appears safe and efficacious, but more data from specifically designed studies are needed.
Publish Date	2022-11-25 02:19
Citation	Pizzoferrato M, Puca P, Ennas S, Cammarota G, Guidi L. Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure. World J Gastroenterol 2022; 28(44): 6258-6270
URL	https://www.wjgnet.com/1007-9327/full/v28/i44/6258.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i44.6258

Full Article (PDF)	WJG-28-6258.pdf
Full Article (Word)	WJG-28-6258.docx
Manuscript File	79880_Auto_Edited-LM.docx
Answering Reviewers	79880-Answering reviewers.pdf
Audio Core Tip	79880-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	79880-Conflict-of-interest statement.pdf
Copyright License Agreement	79880-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	79880-Language certificate.pdf
Peer-review Report	79880-Peer-review(s).pdf
Scientific Misconduct Check	79880-Bing-Wang JJ-2.png
Scientific Editor Work List	79880-Scientific editor work list.pdf
CrossCheck Report	79880-CrossCheck report.pdf